Patents by Inventor Timothy Barrett

Timothy Barrett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230167087
    Abstract: The present invention provides a compound of Formula (I), or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula (I) for treating metabolic conditions, such as type 2 diabetes mellitus, heart failure, diabetic kidney disease, and non-alcoholic steatohepatitis.
    Type: Application
    Filed: February 4, 2021
    Publication date: June 1, 2023
    Inventors: Timothy Barrett DURHAM, Junliang HAO, Richard Duane JOHNSTON
  • Publication number: 20220017496
    Abstract: The present invention provides a compound of Formula I. or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treating metabolic conditions, such as type 2 diabetes mellitus, heart failure, diabetic kidney disease, and non-alcoholic steatohepatitis.
    Type: Application
    Filed: September 17, 2021
    Publication date: January 20, 2022
    Inventors: David Andrew COATES, Timothy Barrett DURHAM, Richard Duane JOHNSTON, Steven Marc MASSEY, Patrick Gianpietro SPINAZZE, Douglas Richard STACK, James Lee TOTH
  • Patent number: 11154550
    Abstract: Provided is a method of treating and/or preventing Wolfram Syndrome (WS)-related neurodegeneration (i.e. of Wolfram Syndrome-Associated Neuronal Degeneration), by increasing the expression and/or functional activity of p21. A method of screening for pharmacological agents useful in treating and/or preventing such conditions is also provided.
    Type: Grant
    Filed: September 27, 2013
    Date of Patent: October 26, 2021
    Assignee: The University of Birmingham
    Inventors: Zsuzsanna Nagy, Timothy Barrett
  • Patent number: 11124500
    Abstract: The present invention provides a compound of Formula I or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treating metabolic conditions, such as type 2 diabetes mellitus, heart failure, diabetic kidney disease, and non-alcoholic steatohepatitis.
    Type: Grant
    Filed: June 16, 2020
    Date of Patent: September 21, 2021
    Assignee: Eli Lilly and Company
    Inventors: David Andrew Coates, Timothy Barrett Durham, Richard Duane Johnston, Steven Marc Massey, Patrick Gianpietro Spinazze, Douglas Richard Stack, James Lee Toth
  • Publication number: 20200392118
    Abstract: The present invention provides a compound of Formula I or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treating metabolic conditions, such as type 2 diabetes mellitus, heart failure, diabetic kidney disease, and non-alcoholic steatohepatitis.
    Type: Application
    Filed: June 16, 2020
    Publication date: December 17, 2020
    Inventors: David Andrew COATES, Timothy Barrett DURHAM, Richard Duane JOHNSTON, Steven Marc MASSEY, Patrick Gianpietro SPINAZZE, Douglas Richard STACK, James Lee TOTH
  • Patent number: 10781212
    Abstract: The present invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treating metabolic conditions, such as type 2 diabetes mellitus, heart failure, diabetic kidney disease, and non-alcoholic steatohepatitis.
    Type: Grant
    Filed: August 29, 2019
    Date of Patent: September 22, 2020
    Assignee: Eli Lilly and Company
    Inventor: Timothy Barrett Durham
  • Publication number: 20200071331
    Abstract: The present invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treating metabolic conditions, such as type 2 diabetes mellitus, heart failure, diabetic kidney disease, and non-alcoholic steatohepatitis.
    Type: Application
    Filed: August 29, 2019
    Publication date: March 5, 2020
    Inventor: Timothy Barrett DURHAM
  • Patent number: 10062223
    Abstract: An intermediary access device enables a user electronic device to communicate with a vehicle's onboard computer system. A first wireless transceiver of the intermediary access device is used to establish a secure wireless communication channel between the intermediary access device and a vehicle on-board computer system. A second wireless transceiver of the intermediary access device is used to establish a user-initiated communication channel between the intermediary access device and a user electronic device. User commands and vehicle information can then be transmitted between the vehicle on-board computer system and the user electronic device via the intermediary access device in a safe, secure and efficient manner.
    Type: Grant
    Filed: August 30, 2013
    Date of Patent: August 28, 2018
    Assignee: Bayerische Motoren Werke Akttiengesellschaft
    Inventors: Hans-Peter Fischer, Timothy Barrett, Andreas Kasprzok, Keith Payne, Johannes Michael Zahn
  • Patent number: 9776992
    Abstract: 1-Oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamide compounds, formulations containing those compounds, and their use as AICARFT inhibitors.
    Type: Grant
    Filed: November 24, 2015
    Date of Patent: October 3, 2017
    Assignee: Eli Lilly and Company
    Inventors: Harold Burns Brooks, Robert Dean Dally, Timothy Barrett Durham, Kevin Robert Fales, Kwame Frimpong, Jefferson Ray McCowan, Frank George Njoroge, Timothy Alan Shepherd, Chong Si, Kenneth Jeff Thrasher, James Lee Toth, Zhipei Wu
  • Publication number: 20170233378
    Abstract: 1-Oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamide compounds, formulations containing those compounds, and their use as AICARFT inhibitors.
    Type: Application
    Filed: November 24, 2015
    Publication date: August 17, 2017
    Applicant: Eli Lilly and Company
    Inventors: Harold Burns BROOKS, Robert Dean DALLY, Timothy Barrett DURHAM, Kevin Robert FALES, Kwame FRIMPONG, Jefferson Ray MCCOWAN, Frank George NJOROGE, Timothy Alan SHEPHERD, Chong SI, Kenneth Jeff THRASHER, James Lee TOTH, Zhipei WU
  • Patent number: 9206139
    Abstract: The present invention provides compounds having the formula: wherein R1 is selected from methyl, ethyl, propyl, cyclopropyl, and dimethyl, or a pharmaceutically acceptable salt thereof, along with methods and intermediates for their preparation, and uses thereof.
    Type: Grant
    Filed: October 18, 2013
    Date of Patent: December 8, 2015
    Assignee: Eli Lilly and Company
    Inventors: Timothy Barrett Durham, Jothirajah Marimuthu, Michael Robert Wiley
  • Publication number: 20150246037
    Abstract: Provided is a method of treating and/or preventing Wolfram Syndrome (WS)-related neurodegeneration (i.e. of Wolfram Syndrome-Associated Neuronal Degeneration), by increasing the expression and/or functional activity of p21. A method of screening for pharmacological agents useful in treating and/or preventing such conditions is also provided.
    Type: Application
    Filed: September 27, 2013
    Publication date: September 3, 2015
    Applicant: The University of Birmingham
    Inventors: Zsuzsanna Nagy, Timothy Barrett
  • Publication number: 20150218107
    Abstract: The present invention provides compounds having the formula: wherein R1 is selected from methyl, ethyl, propyl, cyclopropyl, and dimethyl, or a pharmaceutically acceptable salt thereof, along with methods and intermediates for their preparation, and uses thereof.
    Type: Application
    Filed: October 18, 2013
    Publication date: August 6, 2015
    Applicant: Eli Lily and Company
    Inventors: Timothy Barrett Durham, Jothirajah Marimuthu, Michael Robert Wiley
  • Publication number: 20150061828
    Abstract: An intermediary access device enables a user electronic device to communicate with a vehicle's onboard computer system. A first wireless transceiver of the intermediary access device is used to establish a secure wireless communication channel between the intermediary access device and a vehicle on-board computer system. A second wireless transceiver of the intermediary access device is used to establish a user-initiated communication channel between the intermediary access device and a user electronic device. User commands and vehicle information can then be transmitted between the vehicle on-board computer system and the user electronic device via the intermediary access device in a safe, secure and efficient manner.
    Type: Application
    Filed: August 30, 2013
    Publication date: March 5, 2015
    Applicant: Bayerische Motoren Werke Aktiengesellschaft
    Inventors: Hans-Peter FISCHER, Timothy BARRETT, Andreas KASPRZOK, Keith PAYNE, Johannes Michael ZAHN
  • Patent number: 8802023
    Abstract: A steam autoclave (steam sterilization system) has a door for opening and closing an opening that defines the entrance to and exit from a steam sterilization chamber. The door may be latched and locked and pneumatically sealed when in a closed position. Preferably, the door has a convex portion that projects into the sterilization chamber when the door is in a closed position for aiding in providing an even distribution of steam throughout the sterilization chamber during operation of the steam autoclave.
    Type: Grant
    Filed: September 29, 2011
    Date of Patent: August 12, 2014
    Assignee: OnSite Sterilization LLC
    Inventors: Robert W. Lewis, Timothy A. Barrett
  • Patent number: 8784732
    Abstract: A steam autoclave for treating Regulated Medical Waste that uses a condensate drainage system that provides for condensate drainage while the steam autoclave chamber remains pressurized during the steam treatment cycle to create pressure variations in the autoclave which are used to initiate the introduction of repeated bursts of steam into the waste during the steam treatment cycle. The repeated bursts of steam into the autoclave during the steam treatment cycle agitates the steam and waste contained in the autoclave, thereby enhancing steam penetration into the waste being treated and thereby enhancing biological kill efficacy.
    Type: Grant
    Filed: August 16, 2011
    Date of Patent: July 22, 2014
    Assignee: OnSite Sterilization LLC
    Inventors: Robert W. Lewis, Timothy A. Barrett
  • Publication number: 20130268522
    Abstract: A system and method for content exclusion from a multi-domain search, where search results are prioritized or potentially excluded based on content provided by a service provider. The system and method provide for providing access to a network by a primary service provider, the network including multiple sources of content; receiving at least one search parameter; performing a search for content based on the received at least one search parameter; prioritizing results of the search based on content provided by the primary service provider; and displaying the prioritized results. In one embodiment, the system and method further includes excluding at least one search result if the at least one search result matches content provided by the primary service provider.
    Type: Application
    Filed: June 28, 2010
    Publication date: October 10, 2013
    Applicant: THOMSON LICENSING
    Inventor: Timothy A. Barrett
  • Patent number: 8546132
    Abstract: An apparatus for safely and conveniently placing and retrieving biological indicators and/or computerized data tracers from deep within loads of Regulated Medical/Infectious Waste comprises a rod with a cavity for holding the biological indicators and/or computerized data tracers. Preferably, the rod is tapered to a point on one end, has a handle on the opposite end, and has a cover to enclose the cavity. Additionally, it is preferred that the rod is fitted with a movable sealing ring of soft material for sealing the area where the rod penetrates the waste load.
    Type: Grant
    Filed: November 1, 2010
    Date of Patent: October 1, 2013
    Inventors: Robert W. Lewis, Timothy A. Barrett
  • Patent number: 8518340
    Abstract: A steam autoclave has a main drain line and an auxiliary drain line through which condensate in the autoclave chamber is drained, the auxiliary drain line having a conduit extending therethrough defining a path for condensate to move through the auxiliary drain line, and at least a portion of the conduit having a cross-section sized to permit effective draining of condensate through the conduit while the autoclave chamber is pressurized without substantial loss of steam pressure in the autoclave chamber. A sensor may be positioned in the autoclave chamber for sensing a pressure drop during condensate draining while the autoclave chamber is pressurized and for initializing insertion of additional pressurized steam into the autoclave chamber as needed to maintain adequate steam pressure in the autoclave chamber.
    Type: Grant
    Filed: September 27, 2007
    Date of Patent: August 27, 2013
    Inventors: Robert W. Lewis, Timothy A. Barrett
  • Patent number: 8318104
    Abstract: An apparatus for treating waste comprises a gravity drop steam heating tower for heating the waste to the biological kill temperature using pressurized steam, a first feed member for feeding the waste to be sterilized to the gravity drop steam heating tower, and a vaporization system. The vaporization system includes a heating chamber for facilitating vaporization of liquids in the waste, a conveying member for conveying the waste from the lower end portion of the gravity drop steam heating tower into and through the heating chamber, and a vaporization chamber for receiving the waste from the heating chamber and for releasing vapor entrained in the waste into the vaporization chamber.
    Type: Grant
    Filed: March 15, 2011
    Date of Patent: November 27, 2012
    Inventors: Robert W. Lewis, Timothy Barrett